Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Medincell SA
MEDCLCurrent price
17.8 EUR
-0.14 EUR (-0.78%)
Last closed
17.9 EUR
Company
www.medincell.com
ISIN
FR0004065605
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
525 963 210 EUR
Yield for 12 month
+191.80 %
1Y
3Y
5Y
10Y
15Y
MEDCL
MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults. The company's products in development include mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation; and mdc-TJK, a subcutaneous injection that is in Phase III clinical trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. MedinCell S.A. was incorporated in 2003 and is headquartered in Jacou, France. Address: 3 rue des FrEres LumiEre, Jacou, France, 34830
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
20.42 EURP/E ratio
–Dividend Yield
–Current Year
+9 101 790 EUR
Last Year
+9 965 412 EUR
Current Quarter
+3 794 093 EUR
Last Quarter
+7 038 973 EUR
Current Year
+9 230 779 EUR
Last Year
+13 760 513 EUR
Current Quarter
+3 794 093 EUR
Last Quarter
+8 243 207 EUR
Key Figures MEDCL
1 year
3 years
5 years
10 years
EBITDA
-20 200 896 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-39.49 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
20.42 EUR
Revenue TTM
12 037 299 EUR
Book Value
-1.41 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-36.7 %
Dividend Yield
–
Gross Profit TTM
13 760 513 EUR
Earnings per share
-0.89 EUR
Diluted Eps TTM
-0.89 EUR
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-209.61 %
Dividend Analytics MEDCL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MEDCL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MEDCL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
61.2917
Price Sales TTM
43.6945
Enterprise Value EBITDA
-11.8173
Price Book MRQ
27.5888
Financials MEDCL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MEDCL
For 52 weeks
5.97 EUR
19.15 EUR
50 Day MA
16.1 EUR
Shares Short Prior Month
–
200 Day MA
13.81 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart